EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Influence of prior myocardial infarction on outcome in patients with ischaemic HFrEF: insights from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry

Tobias Heer, Uwe Zeymer, Matthias Hochadel, Lutz Frankenstein, Matthias Pauschinger, Rainer Hambrecht, Oliver Bruder, Michael Böhm, Lars S Maier, Ralf Zahn, Jochen Senges

Clinical Research in Cardiology · 2025

DOI: 10.1007/s00392-024-02455-w ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Tobias Heer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, München Klinik Neuperlach, Academic Teaching Hospital, LMU University of Munich, Oskar-Maria-Graf-Ring 51, 81737, Munich, G…. Hauptthemen laut MEDLINE: Heart Failure, Myocardial Infarction. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medtronic, Novartis Pharma, Sanofi-Aventis Deutschland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is scarce information about the influence of prior myocardial infarction (pMI) on outcomes in patients (pts) with ischaemic HFrEF. We analysed data from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry.

Methods

EVITA-HF comprises web-based case report data on demography, diagnostic measures, adverse events and 1-year follow-up of patients hospitalized for chronic heart failure ≥ 3 months (CHF) and an ejection fraction ≤ 40%. In the present study, we focused on the outcomes of pts with and without pMI in ischaemic HFrEF.

Results

Between February 2009 and November 2015, a total of 2075 consecutive pts with ischaemic HFrEF were included from 16 centres in Germany. A total of 81.2% were male, and the mean age was 71 years. A total of 61.5% of the pts with ischaemic HFrEF had a history of pMI. These pts were treated less often with PCI (20.0 vs. 31.0%, p < 0.001) or CABG (3.8 vs. 7.7%, p < 0.001). They more often received an ICD (40.9 vs. 28.7%, p < 0.001), but less often a CRT-D (11.3 vs. 19.4%, p < 0.001). After multivariate adjustment, pts with pMI had a greater all-cause mortality after 1 year than those without pMI (hazard ratio 1.4; 95% CI, 1.10–1.79, p = 0.007). The combined endpoint of death, resuscitation or ICD shock after 1 year was greater in patients with pMI (20.8 vs. 16.4%, p = 0.03). Mobility was more often reduced in pts with pMI (46.8% vs. 40.1%, p = 0.03), and overall health status was more frequently worse in patients with pMI than in those 12 months ago (23.1 vs. 15.9%, p = 0.01). More than a quarter of the pts with ischaemic HFrEF were anxious or depressive. Conclusion pMI in patients with CHF and ischaemic HFrEF was associated with increased mortality, increased event rates, and worsened health status. Hence, the subgroup of pts with ischaemic HFrEF and pMI is at higher risk and deserves special attention. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMyocardial InfarctionHumansMaleFemaleAgedRegistriesGermanyStroke VolumeMiddle AgedRisk FactorsTreatment OutcomeTime FactorsFollow-Up StudiesVentricular Function, LeftEvidence-Based MedicinePercutaneous Coronary Intervention

Stichwörter der Autor:innen

Health statusIschaemic HFrEFOutcomePrior myocardial infarction

Autor:innen und Institutionen

  • Department of Cardiology, München Klinik Neuperlach, Academic Teaching Hospital, LMU University of Munich, Oskar-Maria-Graf-Ring 51, 81737, Munich, Germany. tobias.heer@muenchen-klinik.de.
  • Department of Cardiology, Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen, Germany.
  • Stiftung Institut für Herzinfarktforschung, Ludwigshafen, Germany.
  • Department of Internal Medicine III, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Med. Klinik 8 - Kardiologie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität, Klinikum Nürnberg, Nuremberg, Germany.
  • Department of Internal Medicine II, Krankenhaus Links der Weser, Bremen, Germany.

Förderung

  • Medtronic
  • Novartis Pharma
  • Sanofi-Aventis Deutschland
  • Klinikum der Universität München

Zitieren

APA

Heer, T., Zeymer, U., Hochadel, M., Frankenstein, L., Pauschinger, M., Hambrecht, R., Bruder, O., Böhm, M., Maier, L. S., Zahn, R., & Senges, J. (2025). Influence of prior myocardial infarction on outcome in patients with ischaemic HFrEF: insights from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02455-w

Vancouver

Heer T, Zeymer U, Hochadel M, Frankenstein L, Pauschinger M, Hambrecht R, et al. Influence of prior myocardial infarction on outcome in patients with ischaemic HFrEF: insights from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-024-02455-w

BibTeX
@article{Heer2025,
  author = {Heer, Tobias and Zeymer, Uwe and Hochadel, Matthias and Frankenstein, Lutz and Pauschinger, Matthias and Hambrecht, Rainer and Bruder, Oliver and Böhm, Michael and Maier, Lars S and Zahn, Ralf and Senges, Jochen},
  title = {Influence of prior myocardial infarction on outcome in patients with ischaemic HFrEF: insights from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry},
  journal = {Clinical Research in Cardiology},
  year = {2025},
  doi = {10.1007/s00392-024-02455-w}
}
Kostenlos starten →